BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

3279 related articles for article (PubMed ID: 398141)

  • 1. Biological and biochemical characteristics of the tetrapeptide tuftsin, Thr-Lys-Pro-Arg.
    Najjar VA
    Adv Exp Med Biol; 1979; 121(A):131-47. PubMed ID: 398141
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuftsin, a natural activator of phagocyte cells: an overview.
    Najjar VA
    Ann N Y Acad Sci; 1983; 419():1-11. PubMed ID: 6370072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuftsin, a natural activator of phagocytic functions including tumoricidal activity.
    Najjar VA; Konopinska D; Chaudhuri MK; Schmidt DE; Linehan L
    Mol Cell Biochem; 1981 Dec; 41():3-12. PubMed ID: 6895774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal activity of tuftsin.
    Martinez J; Winternitz F
    Mol Cell Biochem; 1981 Dec; 41():123-36. PubMed ID: 6799777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of familial and acquired phagocytosis deficiency involving the tetrapeptide, thr-lys-pro-arg, tuftsin.
    Najjar VA
    Exp Cell Biol; 1978; 46(1-2):114-26. PubMed ID: 579629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The similarity between tuftsin (Thr-Lys-Pro-Arg) receptors and tuftsin antibody: a case of induced molecular mimicry.
    Chaudhuri MK; Konopińska D; Bump NJ; Najjar VA
    Ann N Y Acad Sci; 1983; 419():135-42. PubMed ID: 6324634
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-tumour effect of the physiological tetrapeptide, tuftsin.
    Nishioka K
    Br J Cancer; 1979 Mar; 39(3):342-5. PubMed ID: 582417
    [No Abstract]   [Full Text] [Related]  

  • 8. Tuftsin (an Ig-associated tetrapeptide) triggers the immunogenic function of macrophages: implications for activation of programmed cells.
    Tzehoval E; Segal S; Stabinsky Y; Fridkin M; Spirer Z; Feldman M
    Proc Natl Acad Sci U S A; 1978 Jul; 75(7):3400-4. PubMed ID: 277940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tuftsin stimulates the release of oxygen radicals and thromboxane from macrophages.
    Hartung HP; Toyka KV
    Immunol Lett; 1983 Jan; 6(1):1-6. PubMed ID: 6687720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of tuftsin.
    Nishioka K; Babcock GF; Phillips JH; Noyes RD
    Mol Cell Biochem; 1981 Dec; 41():13-8. PubMed ID: 6895773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the peptide chain length of new elongated tuftsin analogs on phagocytosis process.
    Konopińska D; Kazanowska B; Bogusławska-Jaworska J
    Int J Pept Protein Res; 1984 Sep; 24(3):267-73. PubMed ID: 6594319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuftsin, Thr-Lys-Pro-Arg. Anatomy of an immunologically active peptide.
    Fridkin M; Gottlieb P
    Mol Cell Biochem; 1981 Dec; 41():73-97. PubMed ID: 7035869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biochemical aspects of tuftsin deficiency syndrome.
    Najjar VA
    Med Biol; 1981 Jun; 59(3):134-8. PubMed ID: 6895538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tuftsin--new analogues and properties].
    Wardowska A; Dzierzbicka K; Myśliwski A
    Postepy Biochem; 2007; 53(1):60-5. PubMed ID: 17718389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The requirement of membrane sialic acid in the stimulation of phagocytosis by the natural tetrapeptide, tuftsin.
    Constantopoulos A; Najjar VA
    J Biol Chem; 1973 Jun; 248(11):3819-22. PubMed ID: 4350645
    [No Abstract]   [Full Text] [Related]  

  • 16. The clinical and physiological aspects of tuftsin deficiency syndromes exhibiting defective phagocytosis.
    Najjar VA
    Klin Wochenschr; 1979 Aug; 57(15):751-6. PubMed ID: 385971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuftsin-macrophage interaction: specific binding and augmentation of phagocytosis.
    Bar-Shavit Z; Stabinsky Y; Fridkin M; Goldman R
    J Cell Physiol; 1979 Jul; 100(1):55-62. PubMed ID: 381320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tuftsin: an immunomodulating peptide hormone and its clinical potential as a natural biological response modifier.
    Nishioka K; Amoscato AA; Babcock GF; Banks RA; Phillips JH
    Cancer Invest; 1984; 2(1):39-49. PubMed ID: 6322938
    [No Abstract]   [Full Text] [Related]  

  • 19. Tuftsin (Thr-Lys-Pro-Arg), a natural modulator of macrophage activity: further studies.
    Bump NJ; Najjar VA
    Mol Cell Biochem; 1984 Sep; 63(2):137-42. PubMed ID: 6493218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive action of the SP1-4 tetrapeptide and of some tuftsin analogs.
    Semion IZ; Nawrocka E; Słoń J; Tartar A; Obuchowicz E; Gołba K; Herman ZS
    Pol J Pharmacol Pharm; 1990; 42(4):393-401. PubMed ID: 1711198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 164.